Anzeige
Meldung des Tages: US-Goldprojekt vor dem Durchbruch: Warum Investoren jetzt aufmerksam werden

Haemonetics News

Aktie
WKN:  881782 ISIN:  US4050241003 US-Symbol:  HAE Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
48,50 €
-0,28 €
-0,57%
11:43:02 Uhr
Depot/Watchlist
Marktkapitalisierung *
3,19 Mrd. €
Streubesitz
-
KGV
18,05
Index-Zuordnung
-

Haemonetics News

01.04.26 - PR Newswire
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 PR Newswire
30.03.26 - PR Newswire
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System PR Newswire
23.02.26 - PR Newswire
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology PR Newswire
20.02.26 - PR Newswire
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference PR Newswire
05.02.26 - PR Newswire
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website PR Newswire
09.01.26 - PR Newswire
Haemonetics Acquires Vivasure Medical Limited
Haemonetics Acquires Vivasure Medical Limited PR Newswire
09.01.26 - PR Newswire
Haemonetics Acquires Vivasure Medical Limited
Haemonetics Acquires Vivasure Medical Limited PR Newswire
07.01.26 - PR Newswire
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 PR Newswire
02.01.26 - PR Newswire
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference PR Newswire
06.11.25 - PR Newswire
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website PR Newswire
09.10.25 - PR Newswire
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 PR Newswire
07.08.25 - PR Newswire
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website PR Newswire
09.07.25 - PR Newswire
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 PR Newswire
30.05.25 - PR Newswire
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference PR Newswire
08.05.25 - PR Newswire
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire

Newssuche

Videos

newspaper
07.04.26 -6,91%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »